Published in J Clin Pathol on December 01, 1970
The mechanism of antigen-induced electrophoretic mobility reduction of guinea-pig macrophages. Clin Exp Immunol (1972) 1.40
Lymphocyte sensitization in sarcoidosis. Br Med J (1971) 1.39
Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation. Br J Cancer Suppl (1973) 1.21
Sensitized lymphocytes in muscular dystrophy: evidence for a neural factor in pathogenesis. J Neurol Neurosurg Psychiatry (1971) 1.05
Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science (1966) 13.12
Lymphocyte transformation in vitro measured by tritiated thymidine uptake. I. Lymphocyte culture techniques. Int Arch Allergy Appl Immunol (1970) 5.67
Response of human blood lymphocytes to tuberculin PPD in tissue culture. Immunology (1967) 4.09
Technique and results of isolation of cancer cells from the circulating blood. AMA Arch Surg (1958) 2.90
Studies on the origin and reactive ability in vivo of peritoneal exudate cells in delayed hypersensitivity. Int Arch Allergy Appl Immunol (1967) 2.51
Medical student selection: a tentative attempt to establish a code of practice. Br Med J (1980) 7.21
Lymphocyte transformation in vitro measured by tritiated thymidine uptake. I. Lymphocyte culture techniques. Int Arch Allergy Appl Immunol (1970) 5.67
Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science (2000) 4.48
Virulence of antibiotic-resistant Salmonella typhimurium. Proc Natl Acad Sci U S A (1998) 4.28
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature (1991) 3.86
Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med (1981) 3.85
Consultation length and outcome in two group general practices. J R Coll Gen Pract (1983) 3.76
Brief report: fulminating fat embolism syndrome caused by paradoxical embolism through a patent foramen ovale. N Engl J Med (1993) 3.55
Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr (1997) 3.38
Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol (1996) 3.20
Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol Microbiol (2001) 2.94
Relative ion permeability of normal and cystic fibrosis nasal epithelium. J Clin Invest (1983) 2.72
Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir. Antimicrob Agents Chemother (1998) 2.67
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Paper and people: the work of the casualty reception clerk. Sociol Health Illn (1989) 2.54
Prospective analysis of stoma-related complications. Colorectal Dis (2005) 2.35
Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med (1991) 2.34
Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: implications for celiac disease diagnosis during routine endoscopy. Am J Gastroenterol (2001) 2.30
The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med (1997) 2.28
Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (1984) 2.14
Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature (1993) 2.04
RCPE UK consensus statement on diabetes. J R Coll Physicians Edinb (2010) 2.03
Comparison of sevoflurane and propofol with rocuronium for modified rapid-sequence induction of anaesthesia. Anaesthesia (1999) 1.98
Prevalence of celiac disease and its endoscopic markers among patients having routine upper gastrointestinal endoscopy. Am J Gastroenterol (1999) 1.93
Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site. J Mol Biol (2000) 1.78
Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol (1999) 1.77
Geographic variation in the onset of decline of ischemic heart disease mortality in the United States. Am J Public Health (1986) 1.77
Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium. Mol Microbiol (1999) 1.75
Macrophage recruitment during limb development and wound healing in the embryonic and foetal mouse. J Cell Sci (1994) 1.74
Fusidic acid-resistant mutants define three regions in elongation factor G of Salmonella typhimurium. Gene (1994) 1.74
Lateral spine radiographs before androgen deprivation treatment detect a high incidence of undiagnosed vertebral fragility fractures in men with advanced prostate cancer. J Urol (2011) 1.72
A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet (2001) 1.70
Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia. Br J Anaesth (1999) 1.69
Head injuries: a study evaluating the impact of the NICE head injury guidelines. Emerg Med J (2005) 1.66
The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood (1998) 1.66
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet (2005) 1.63
Muller's ratchet decreases fitness of a DNA-based microbe. Proc Natl Acad Sci U S A (1996) 1.63
Isolation of Yersinia enterocolitica from milk and a dairy farm in Australia. J Appl Bacteriol (1979) 1.63
Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros (2011) 1.54
Lack of mature B cells in nude mice with X-linked immune deficiency. J Exp Med (1982) 1.52
Bioelectric properties and ion flow across excised human bronchi. J Appl Physiol Respir Environ Exerc Physiol (1984) 1.52
The shifting stroke belt. Changes in the geographic pattern of stroke mortality in the United States, 1962 to 1988. Stroke (1995) 1.51
Increased cholecystectomy rate in the laparoscopic era: a study of the potential causative factors. Surg Endosc (2006) 1.50
Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders. J Neurol Neurosurg Psychiatry (1969) 1.49
Community health monitoring: taking the pulse of America's children. Matern Child Health J (1998) 1.47
Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor. Lancet (1968) 1.46
Activated ras oncogenes in human thyroid cancers. Cancer Res (1988) 1.45
Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. J Clin Microbiol (1997) 1.44
Cellular and humoral responses to measles in subacute sclerosing panencephalitis. Lancet (1969) 1.44
Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology (1994) 1.43
Homologous recombination between the tuf genes of Salmonella typhimurium. J Mol Biol (1996) 1.43
Clinical trial of iron therapy of psychomotor function in anaemic women. Br Med J (1970) 1.41
Invasion of neurones in vitro by non immune lymphocytes. An electron microscopic study. Br J Exp Pathol (1968) 1.41
Low-dose clonidine infusion during labour. Br J Anaesth (1999) 1.40
Use of hyperbaric oxygen in rheumatic diseases: case report and critical analysis. Lupus (1995) 1.39
Is midwifery safe in the embrace of the UKCC? Midwives (1995) (1995) 1.38
Benign vaginal polyp: a histological, histochemical and immunohistochemical study of 20 polyps with comparison to normal vaginal subepithelial layer. Histopathology (1992) 1.38
Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study. Arch Intern Med (1991) 1.38
Sequence heterogeneity and anomalous electrophoretic mobility of kinetoplast minicircle DNA from Leishmania tarentolae. Gene (1984) 1.36
Lymphocyte trnsformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases. Lancet (1968) 1.36
Explaining oropharyngeal dysphagia after unilateral hemispheric stroke. Lancet (1997) 1.36
Immunological aspects of polymyositis. The in vitro activity of lymphocytes on incubation with muscle antigen and with muscle cultures. Q J Med (1971) 1.35
Phylogenetic characterization of epibiotic bacteria in the accessory nidamental gland and egg capsules of the squid Loligo pealei (Cephalopoda:Loliginidae). Environ Microbiol (2001) 1.31
Immunological aspects of systemic sclerosis in vitro activity of lymphocytes from patients with the disorder. Br J Dermatol (1971) 1.30
Lymphocyte transformation in the Guillain-Barré syndrome. Lancet (1969) 1.29
The effects of cytokines and growth factors on osteoblastic cells. Bone (1995) 1.28
Doctors' and nurses' perceptions of ethical problems in end-of-life decisions. J Adv Nurs (2001) 1.28
Lymphocyte transformation using whole blood cultures: an analysis of responses. J Immunol Methods (1972) 1.26
Extended preservation of non-heart-beating donor livers with normothermic machine perfusion. Br J Surg (2002) 1.25
The calibration of a whole-body radioactivity counter for the measurement of body potassium content in clinical studies. Clin Sci (1967) 1.24
BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years. Br J Cancer (2012) 1.24
Report and abstracts of the Third International Workshop on Chromosome 9. Cambridge, United Kingdom, 9-11 April, 1994. Ann Hum Genet (1994) 1.23
Lymphocyte sensitivity to encephalitogenic factor in guinea pigs with experimental allergic encephalomyelitis as shown by in vitro inhibition of macrophage migration. Int Arch Allergy Appl Immunol (1968) 1.21
Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer. Cancer (1972) 1.19
Specific inhibitory action of polyunsaturated fatty acids on lymphocyte transformation induced by PHA and PPD. Int Arch Allergy Appl Immunol (1975) 1.18
Comparison of the traditional paper visual analogue scale questionnaire with an Apple Newton electronic appetite rating system (EARS) in free living subjects feeding ad libitum. Eur J Clin Nutr (1998) 1.18
Macrophages in tissues and in vitro. Curr Opin Immunol (1992) 1.17
Geographic variation in declining ischemic heart disease mortality in the United States, 1968-1978. I. Rates and change, whites aged 35-74 years. Am J Epidemiol (1985) 1.16
Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. Cancer Res (1987) 1.16
On the mode of action of antilymphocytic serum: experiments on electrophoretic mobility of macrophages in experimental allergic encephalomyelitis. Clin Exp Immunol (1970) 1.15
Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection. Br J Cancer Suppl (1973) 1.15
Growth and translation elongation rate are sensitive to the concentration of EF-Tu. Mol Microbiol (1993) 1.15
Diversifying microbial natural products for drug discovery. Appl Microbiol Biotechnol (2003) 1.13
In-vitro inhibition by unsaturated fatty acids of the PPD- and PHA-induced lymphocyte response. Klin Wochenschr (1974) 1.13
Anti-macrophage component of antilymphocytic serum. Lancet (1969) 1.12
Fusidic acid-resistant EF-G perturbs the accumulation of ppGpp. Mol Microbiol (2000) 1.12
The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders. Health Technol Assess (2012) 1.12
Econometric analyses of national health expenditures: can positive economics help to answer normative questions? Health Econ (1993) 1.12
Mutant ribosomes can generate dominant kirromycin resistance. J Bacteriol (1991) 1.11
Lymphocyte sensitivity in cancer. Br Med J (1971) 1.09
Chromosomal assignment of c-MEL, a human transforming oncogene, to chromosome 19 (p13.2-q13.2). Somat Cell Mol Genet (1986) 1.09
A single amino acid substitution in elongation factor Tu disrupts interaction between the ternary complex and the ribosome. J Bacteriol (1993) 1.09
Toxicity of motor neurone disease serum for myelin in tissue culture. Br Med J (1965) 1.09
Stressful life events and the onset of a generalized anxiety syndrome. Am J Psychiatry (1987) 1.07
The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants. J Mol Biol (1996) 1.07
A new mutation in 16S rRNA of Escherichia coli conferring spectinomycin resistance. Nucleic Acids Res (1995) 1.07
Evaluation of periodontal treatments using controlled-release tetracycline fibers: clinical response. J Periodontol (1995) 1.05
Discrepancies between whole-body potassium content and exchangeable potassium. J Lab Clin Med (1968) 1.03
Therapeutic results obtained in vaginal mycoses after single-dose treatment with 500 mg clotrimazole vaginal tablets. Am J Obstet Gynecol (1985) 1.03